Baloxavir for flu in hospitalized adults
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests if the antiviral drug baloxavir can help adults hospitalized with influenza recover faster. It compares baloxavir to a placebo to see if it improves symptoms and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a positive test for influenza A or B from a nose or throat swab.
- You need to be admitted to the hospital for your flu.
- Your illness is serious enough to score 4 or higher on a standard hospital warning scale (NEWS2).
- You have not taken baloxavir or other flu antivirals for more than 24 hours for this current episode.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
This study tests two flu medicines, oseltamivir and baloxavir marboxil, to see if they can prevent flu in people who are in the hospital and were exposed to someone with the flu. It may help you avoid getting sick while you are in the hospital.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This trial tests whether a single dose of an antiviral medicine (baloxavir marboxil) can prevent the flu in people who live with someone who has the flu. It's designed for household contacts who are not yet sick but have been exposed.
This study tests a new medication, sebaloxavir marboxil, to see if it can prevent the flu in people who live with someone who has the flu. If you qualify, you would take the study drug and be monitored for a few weeks.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
Hear when a new Influenza Disease; Flu trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.